Upcoming Events
  1. ALTG Consumer Education Workshop

    July 17 @ 10:00 am - 3:00 pm
  2. Open MAC and SAC Meeting

    July 18 @ 8:00 am - 11:00 am
  3. ALTG Annual Scientific Meeting

    July 18 @ 12:00 pm - July 19 @ 5:00 pm
  4. ALTG ASM Dinner

    July 18 @ 6:00 pm - 11:00 pm
  5. 5th ALTG Preceptorship in Lung Cancer

    October 18 @ 8:00 am - October 19 @ 5:00 pm

ALTG 13/008 PEARL: Investigating the impact of early palliative care – L Mileshkin, J Yoong

PEARL is a non-blinded, randomised Phase III study of early referral to palliative care for patients with advanced thoracic cancer. This multicentre, international trial is a collaboration between the ALTG, Palliative Care Clinical Studies Collaborative and NHMRC Clinical Trials Centre. The study received ethics approval in October 2016 with a plan to recruit 200 patients across 25 sites in Australia and New Zealand over a 2 year period, starting in Q1 2017.

The study will evaluate whether early referral to palliative care improves Health-Related Quality of Life, overall survival and use of health care resources in patients with recently diagnosed, advanced thoracic malignancies.

Site selection is ongoing:

State/TerritorySitePIActivation DateRecruitment
NSWConcord HospitalPrunella Blinman
Liverpool HospitalRebecca Strutt
Macarthur Cancer CentreAnnette Tognela
Royal North Shore HospitalNick Pavlakis
The Tweed HospitalEhtesham Abdi
QLDThe Prince Charles HospitalHenry Marshall
Townsville HospitalSuresh Varma
Toowoomba HospitalPatricia Lourdes Lee-Apostol
VICBarwon HealthPeter Martin
Eastern HealthPhillip Parente
Monash HealthPeter Poon
Peter MacCallum Cancer Centre including Royal Melbourne HospitalLinda Mileshkin
St Vincent's HospitalJennifer Phillip
WASir Charles Gairdner HospitalRajesh Thomas

Study Contacts

Study Chair: Linda Mileshkin     linda.mileshkin@petermac.org

CTC Trial Coordinator: David Cannan     PEARL@ctc.usyd.edu.au